This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M (MMM) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 23.11% and 5.92%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for 3M (MMM) This Earnings Season?
by Zacks Equity Research
End-market challenges, high restructuring expenses and forex woes are likely to have affected 3M's (MMM) Q1 performance. Solid demand for respirators and acquired assets might have aided.
3M (MMM) Stock Moves -0.15%: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $198.30, marking a -0.15% move from the previous day.
3M (MMM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
3M (MMM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $196.75, marking a +0.14% move from the previous day.
HC2 Holdings (HCHC) to Sell Insurance Segment & Solidify Portfolio
by Zacks Equity Research
HC2 Holdings' (HCHC) divestment of the insurance business will help it ensure financial flexibility and strengthen the balance sheet as well as allow focus on other key businesses.
General Electric (GE) Arm Wins Grid Infrastructure Deal in Nepal
by Zacks Equity Research
General Electric (GE) receives a multi-million-dollar deal for upgrading three Gas-Insulated Substations in Nepal from 220 kiloVolt to 400 kiloVolt.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $190.69, moving +1.25% from the previous trading session.
Crane (CR) to Gain From End-Market Strength, Inorganic Moves
by Zacks Equity Research
Crane (CR) to gain from end-market strength, acquisitions, solid product offerings and efficient management team. Also, its policy of rewarding shareholders raises the stock's attractiveness.
The Zacks Analyst Blog Highlights: Novo Nordisk, NextEra Energy, 3M Co, General Motors and U.S. Bancorp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novo Nordisk, NextEra Energy, 3M Co, General Motors and U.S. Bancorp
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $191, marking a +1.43% move from the previous day.
Top Analyst Reports for Novo Nordisk, NextEra & 3M Company
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk (NVO), NextEra Energy (NEE), and 3M Company (MMM).
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $181.18, marking a -1.41% move from the previous day.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $178.06, moving +0.54% from the previous trading session.
Danaher (DHR) to Gain on Segmental Strength, Inorganic Actions
by Zacks Equity Research
Danaher (DHR) is poised to benefit from growth opportunities within its segments. Also, gains from acquired assets and divestments as well as shareholder-friendly policies are likely to favor.
Crane (CR) Hosts Annual Investor Day, Raises 2021 Projections
by Zacks Equity Research
Crane (CR) discusses strategic priorities for future growth at its annual investor day. It also provides its long-term view and talks about revision in projections for 2021.
4 Worthy Stocks From Flourishing Diversified Operations Industry
by Payal Jalan
The Zacks Diversified Operations industry is gaining from improving domestic manufacturing activities as well as solid demand in the medical equipment & defense markets. DHR, MMM, CR and GFF are stocks with earnings potential.
Can Industrial ETFs Gain Despite Mixed Q4 Earnings?
by Sweta Jaiswal, FRM
We highlight the impact of Q4 earnings releases of some major players on industrial ETFs with heavy exposure to the same.
Should Value Investors Consider 3M Company (MMM) Stock Now?
by Zacks Equity Research
Is 3M Company (MMM) a great pick from the value investor's perspective right now? Read on to know more.
Zacks Earnings Trends Highlights: JPMorgan, Boeing, 3M, Microsoft and Johnson & Johnson
by Zacks Equity Research
Zacks Earnings Trends Highlights: JPMorgan, Boeing, 3M, Microsoft and Johnson & Johnson
A Positive and Reassuring Earnings Picture
by Sheraz Mian
Estimates for the current and coming quarters are steadily going up, as companies report Q4 results that are mostly better than expected.
A Positive and Reassuring Earnings Picture
by Sheraz Mian
Estimates for the current and coming quarters are steadily going up, as companies report Q4 results that are mostly better than expected.
Company News for Jan 27, 2021
by Zacks Equity Research
Companies In The News Are: JNJ, MMM, FCX, PII
Earnings Outlook a Source of Support for the Market
by Sheraz Mian
The earnings picture is steadily improving, with estimates for the current and coming quarters going up.
Home Prices Rose in November
by Zacks Equity Research
Home Prices Rose in November